Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Tischkowitz

Showing results (241-250 of 258) with videos related to

Pageof 26
Sort By:
Human Mutation|February 16, 2018
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutationsTimothy R Rebbeck, Tara M Friebel, Eitan Friedman, et al.
Journal of the National Cancer Institute|November 21, 2015
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian CancersHuong D Meeks, Honglin Song, Kyriaki Michailidou, et al.
Nature Genetics|March 2, 2016
Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170Alison M Dunning, Kyriaki Michailidou, Karoline B Kuchenbaecker, et al.
Cancer Research|November 15, 2019
Association of Genomic Domains in <i>BRCA1</i> and <i>BRCA2</i> with Prostate Cancer Risk and AggressivenessVivek L Patel, Evan L Busch, Tara M Friebel, et al.
Genetic Epidemiology|March 3, 2020
Transcriptome-wide association study of breast cancer risk by estrogen-receptor statusHelian Feng, Alexander Gusev, Bogdan Pasaniuc, et al.
Plos Genetics|April 2, 2013
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer riskFergus J Couch, Xianshu Wang, Lesley McGuffog, et al.
JAMA|April 8, 2015
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancerTimothy R Rebbeck, Nandita Mitra, Fei Wan, et al.
European Journal of Human Genetics : EJHG|January 14, 2022
Polygenic risk modeling for prediction of epithelial ovarian cancer riskEileen O Dareng, Jonathan P Tyrer, Daniel R Barnes, et al.
NPJ Breast Cancer|November 9, 2019
The <i>FANCM</i>:p.Arg658* truncating variant is associated with risk of triple-negative breast cancerGisella Figlioli, Massimo Bogliolo, Irene Catucci, et al.
Nature Genetics|January 13, 2015
Identification of six new susceptibility loci for invasive epithelial ovarian cancerKaroline B Kuchenbaecker, Susan J Ramus, Jonathan Tyrer, et al.
Pageof 26

Showing results (241-250 of 258) with videos related to

Sort By:
Pageof 26
Human Mutation|February 16, 2018
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutationsTimothy R Rebbeck, Tara M Friebel, Eitan Friedman, et al.
Journal of the National Cancer Institute|November 21, 2015
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian CancersHuong D Meeks, Honglin Song, Kyriaki Michailidou, et al.
Nature Genetics|March 2, 2016
Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170Alison M Dunning, Kyriaki Michailidou, Karoline B Kuchenbaecker, et al.
Cancer Research|November 15, 2019
Association of Genomic Domains in <i>BRCA1</i> and <i>BRCA2</i> with Prostate Cancer Risk and AggressivenessVivek L Patel, Evan L Busch, Tara M Friebel, et al.
Genetic Epidemiology|March 3, 2020
Transcriptome-wide association study of breast cancer risk by estrogen-receptor statusHelian Feng, Alexander Gusev, Bogdan Pasaniuc, et al.
Plos Genetics|April 2, 2013
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer riskFergus J Couch, Xianshu Wang, Lesley McGuffog, et al.
JAMA|April 8, 2015
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancerTimothy R Rebbeck, Nandita Mitra, Fei Wan, et al.
European Journal of Human Genetics : EJHG|January 14, 2022
Polygenic risk modeling for prediction of epithelial ovarian cancer riskEileen O Dareng, Jonathan P Tyrer, Daniel R Barnes, et al.
NPJ Breast Cancer|November 9, 2019
The <i>FANCM</i>:p.Arg658* truncating variant is associated with risk of triple-negative breast cancerGisella Figlioli, Massimo Bogliolo, Irene Catucci, et al.
Nature Genetics|January 13, 2015
Identification of six new susceptibility loci for invasive epithelial ovarian cancerKaroline B Kuchenbaecker, Susan J Ramus, Jonathan Tyrer, et al.
Pageof 26